According to Hikma Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are $0.23 B. In 2022 the company made an earning of $0.23 B a decrease over its 2021 earnings that were of $0.54 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 | $0.23 B | -57.17% |
2021 | $0.54 B | -2.51% |
2020 | $0.55 B | 13.65% |
2019 | $0.49 B | 67.58% |
2018 | $0.29 B | -139.7% |
2017 | -$0.74 B | -451.43% |
2016 | $0.21 B | -33.96% |
2015 | $0.31 B | -12.15% |
2014 | $0.36 B | 21.48% |
2013 | $0.29 B | 125.69% |
2012 | $0.13 B | 40.63% |
2011 | $93.89 M | -22.39% |
2010 | $0.12 B | 27.64% |
2009 | $94.78 M | 48.03% |
2008 | $64.03 M | -23.58% |
2007 | $83.78 M | 10.84% |
2006 | $75.59 M | 17.37% |
2005 | $64.4 M | 9.12% |
2004 | $59.02 M | 98.92% |
2003 | $29.67 M | 55.38% |
2002 | $19.09 M |